1. Home
  2. GLPG vs LADR Comparison

GLPG vs LADR Comparison

Compare GLPG & LADR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLPG
  • LADR
  • Stock Information
  • Founded
  • GLPG 1999
  • LADR 2008
  • Country
  • GLPG Belgium
  • LADR United States
  • Employees
  • GLPG N/A
  • LADR N/A
  • Industry
  • GLPG Biotechnology: Pharmaceutical Preparations
  • LADR Real Estate Investment Trusts
  • Sector
  • GLPG Health Care
  • LADR Real Estate
  • Exchange
  • GLPG Nasdaq
  • LADR Nasdaq
  • Market Cap
  • GLPG 1.8B
  • LADR 1.5B
  • IPO Year
  • GLPG 2005
  • LADR 2014
  • Fundamental
  • Price
  • GLPG $24.77
  • LADR $11.41
  • Analyst Decision
  • GLPG Sell
  • LADR Buy
  • Analyst Count
  • GLPG 5
  • LADR 6
  • Target Price
  • GLPG $26.75
  • LADR $13.29
  • AVG Volume (30 Days)
  • GLPG 159.3K
  • LADR 497.9K
  • Earning Date
  • GLPG 04-23-2025
  • LADR 04-24-2025
  • Dividend Yield
  • GLPG N/A
  • LADR 8.07%
  • EPS Growth
  • GLPG N/A
  • LADR 6.17
  • EPS
  • GLPG 1.16
  • LADR 0.86
  • Revenue
  • GLPG $285,380,474.00
  • LADR $271,184,000.00
  • Revenue This Year
  • GLPG $0.08
  • LADR $9.11
  • Revenue Next Year
  • GLPG $0.23
  • LADR $8.48
  • P/E Ratio
  • GLPG $21.58
  • LADR $13.26
  • Revenue Growth
  • GLPG 14.99
  • LADR 6.98
  • 52 Week Low
  • GLPG $22.36
  • LADR $10.21
  • 52 Week High
  • GLPG $32.17
  • LADR $12.48
  • Technical
  • Relative Strength Index (RSI)
  • GLPG 38.92
  • LADR 42.62
  • Support Level
  • GLPG $24.48
  • LADR $11.20
  • Resistance Level
  • GLPG $25.72
  • LADR $11.64
  • Average True Range (ATR)
  • GLPG 0.51
  • LADR 0.19
  • MACD
  • GLPG -0.15
  • LADR -0.03
  • Stochastic Oscillator
  • GLPG 14.15
  • LADR 37.27

About GLPG Galapagos NV

Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.

About LADR Ladder Capital Corp

Ladder Capital Corp is an internally-managed real estate investment trust that is in commercial real estate finance. The company originates and invests in a diverse portfolio of commercial real estate and real estate-related assets, focusing on senior secured assets. The company's investment activities include: (i) Primary business of originating senior first mortgage fixed and floating rate loans collateralized by commercial real estate with flexible loan structures; (ii) owning and operating commercial real estate, including net leased commercial properties; and (iii) investing in investment-grade securities secured by first mortgage loans on commercial real estate. The company has three reportable segments include loans: which derives maximum profit; securities; and real estate.

Share on Social Networks: